Irinotecan HCl

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

68 API Suppliers, 29 USDMF, 13 CEP/COS, 10 JDMF, 6 EU WC, 12 KDMF, 12 NDC API, 37 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

296 Drugs in Development

296 Drugs in Development

INTERMEDIATES

18 Intermediate Suppliers

18 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

177 FDF Dossiers, 65 FDA Orange Book, 64 Europe, 8 Canada, 10 Australia, 8 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 100MG/5ML (20MG/ML), INJECTABLE;INJECTION - 300MG/15ML (20MG/ML), INJECTABLE;INJECTION - 40MG/2ML (20MG/ML), INJECTABLE, LIPOSOMAL;INTRAVENOUS - EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Kirsch Pharma, 3 Actylis, 1 BioSpectra, 4 Nippon Fine Chemical, 11 Roquette, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

9 Parenteral, 9 Film Formers & Plasticizers, 4 Fillers, Diluents & Binders, 4 Taste Masking, 4 Coating Systems & Additives, 3 Surfactant & Foaming Agents, 3 Emulsifying Agents, 2 Solubilizers, 2 Topical, 2 Co-Processed Excipients, 2 Chewable & Orodispersible Aids, 1 Dry Powder Inhalation, 1 Soft Gelatin, 1 Direct Compression, 1 Thickeners and Stabilizers